Zoghbi Huda Y, a director at Regeneron Pharmaceuticals ($REGN), sold shares on the open market eleven times over the past year, totaling about $1.28 million. Her most recent sale occurred on February 19, 2026. These sales rank her 4,365th among 11,678 individual insiders by sale value, below the average of $8.6 million per insider across about 6.4 transactions. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 49 | $774.68 | 3,292.0000 | 137,600,000 | 1.47% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | M | Common Stock | 1638 | $376.69 | 3,341.0000 | 137,600,000 | 96.18% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 4 | $790.00 | 1,703.0000 | 137,600,000 | 0.23% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 56 | $785.61 | 1,707.0000 | 137,600,000 | 3.18% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 160 | $784.45 | 1,763.0000 | 137,600,000 | 8.32% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 220 | $783.29 | 1,923.0000 | 137,600,000 | 10.27% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 298 | $782.10 | 2,143.0000 | 137,600,000 | 12.21% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 209 | $781.28 | 2,441.0000 | 137,600,000 | 7.89% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 331 | $780.45 | 2,650.0000 | 137,600,000 | 11.10% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 208 | $779.55 | 2,981.0000 | 137,600,000 | 6.52% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 53 | $778.47 | 3,189.0000 | 137,600,000 | 1.63% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 50 | $775.50 | 3,242.0000 | 137,600,000 | 1.52% | 0.00% |
| Feb. 19, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | M | Non-Qualified Stock Option (right to buy) | 1638 | $0.00 | 800.0000 | 137,600,000 | 67.19% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | A | Non-Qualified Stock Option (right to buy) | 1962 | $0.00 | 1,962.0000 | 137,600,000 | 9999.99% | 0.00% |
| Jan. 2, 2026 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | A | Common Stock | 155 | $0.00 | 1,703.0000 | 137,600,000 | 10.01% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | A | Common Stock | 166 | $0.00 | 1,548.0000 | 136,000,000 | 12.01% | 0.00% |
| Jan. 2, 2025 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | A | Non-Qualified Stock Option (right to buy) | 1958 | $0.00 | 1,958.0000 | 136,000,000 | 9999.99% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 1117 | $900.00 | 1,247.0000 | 133,100,000 | 47.25% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | M | Non-Qualified Stock Option (right to buy) | 1117 | $0.00 | 0.0000 | 133,100,000 | 100.00% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | A | Common Stock | 135 | $0.00 | 1,382.0000 | 133,100,000 | 10.83% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | M | Common Stock | 1117 | $391.92 | 2,364.0000 | 133,100,000 | 89.57% | 0.00% |
| Jan. 2, 2024 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | A | Non-Qualified Stock Option (right to buy) | 1607 | $0.00 | 1,607.0000 | 133,100,000 | 9999.99% | 0.00% |
| Oct. 13, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | M | Non-Qualified Stock Option (right to buy) | 1000 | $0.00 | 1,117.0000 | 130,400,000 | 47.24% | 0.00% |
| Oct. 13, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | S | Common Stock | 1000 | $850.00 | 1,247.0000 | 130,400,000 | 44.50% | 0.00% |
| Oct. 13, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | M | Common Stock | 1000 | $391.92 | 2,247.0000 | 130,400,000 | 80.19% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | A | Non-Qualified Stock Option (right to buy) | 1929 | $0.00 | 1,929.0000 | 130,400,000 | 9999.99% | 0.00% |
| Jan. 3, 2023 | REGENERON PHARMACEUTICALS, INC. | $REGN | Zoghbi Huda Y | Director | A | Common Stock | 165 | $0.00 | 1,247.0000 | 130,400,000 | 15.25% | 0.00% |